JP2021001178A5 - - Google Patents
Download PDFInfo
- Publication number
- JP2021001178A5 JP2021001178A5 JP2020143608A JP2020143608A JP2021001178A5 JP 2021001178 A5 JP2021001178 A5 JP 2021001178A5 JP 2020143608 A JP2020143608 A JP 2020143608A JP 2020143608 A JP2020143608 A JP 2020143608A JP 2021001178 A5 JP2021001178 A5 JP 2021001178A5
- Authority
- JP
- Japan
- Prior art keywords
- cell
- isolated placental
- cells
- placental
- methods
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Withdrawn
Links
- 210000004027 cell Anatomy 0.000 description 10
- 230000003169 placental effect Effects 0.000 description 8
- 238000000034 method Methods 0.000 description 3
- 239000000203 mixture Substances 0.000 description 3
- 102000003729 Neprilysin Human genes 0.000 description 2
- 108090000028 Neprilysin Proteins 0.000 description 2
- 230000008774 maternal effect Effects 0.000 description 2
- 210000002901 mesenchymal stem cell Anatomy 0.000 description 2
- 101000599852 Homo sapiens Intercellular adhesion molecule 1 Proteins 0.000 description 1
- 102100037877 Intercellular adhesion molecule 1 Human genes 0.000 description 1
- 102000043129 MHC class I family Human genes 0.000 description 1
- 108091054437 MHC class I family Proteins 0.000 description 1
- 102000015736 beta 2-Microglobulin Human genes 0.000 description 1
- 108010081355 beta 2-Microglobulin Proteins 0.000 description 1
- 210000001185 bone marrow Anatomy 0.000 description 1
- 239000002771 cell marker Substances 0.000 description 1
- 210000004991 placental stem cell Anatomy 0.000 description 1
- 238000003757 reverse transcription PCR Methods 0.000 description 1
Priority Applications (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| JP2022143365A JP2022184911A (ja) | 2014-09-26 | 2022-09-09 | 胎盤幹細胞を使用する糖尿病性足部潰瘍の治療 |
Applications Claiming Priority (10)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US201462056008P | 2014-09-26 | 2014-09-26 | |
| US62/056,008 | 2014-09-26 | ||
| US201562145551P | 2015-04-10 | 2015-04-10 | |
| US62/145,551 | 2015-04-10 | ||
| US201562151726P | 2015-04-23 | 2015-04-23 | |
| US62/151,726 | 2015-04-23 | ||
| US201562170757P | 2015-06-04 | 2015-06-04 | |
| US62/170,757 | 2015-06-04 | ||
| US201562220620P | 2015-09-18 | 2015-09-18 | |
| US62/220,620 | 2015-09-18 |
Related Parent Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2017516161A Division JP2017537057A (ja) | 2014-09-26 | 2015-09-25 | 胎盤幹細胞を使用する糖尿病性足部潰瘍の治療 |
Related Child Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2022143365A Division JP2022184911A (ja) | 2014-09-26 | 2022-09-09 | 胎盤幹細胞を使用する糖尿病性足部潰瘍の治療 |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| JP2021001178A JP2021001178A (ja) | 2021-01-07 |
| JP2021001178A5 true JP2021001178A5 (https=) | 2022-03-02 |
Family
ID=55582072
Family Applications (3)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2017516161A Pending JP2017537057A (ja) | 2014-09-26 | 2015-09-25 | 胎盤幹細胞を使用する糖尿病性足部潰瘍の治療 |
| JP2020143608A Withdrawn JP2021001178A (ja) | 2014-09-26 | 2020-08-27 | 胎盤幹細胞を使用する糖尿病性足部潰瘍の治療 |
| JP2022143365A Pending JP2022184911A (ja) | 2014-09-26 | 2022-09-09 | 胎盤幹細胞を使用する糖尿病性足部潰瘍の治療 |
Family Applications Before (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2017516161A Pending JP2017537057A (ja) | 2014-09-26 | 2015-09-25 | 胎盤幹細胞を使用する糖尿病性足部潰瘍の治療 |
Family Applications After (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2022143365A Pending JP2022184911A (ja) | 2014-09-26 | 2022-09-09 | 胎盤幹細胞を使用する糖尿病性足部潰瘍の治療 |
Country Status (4)
| Country | Link |
|---|---|
| US (1) | US20170290861A1 (https=) |
| EP (1) | EP3197467A4 (https=) |
| JP (3) | JP2017537057A (https=) |
| WO (1) | WO2016049485A1 (https=) |
Families Citing this family (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN113116933A (zh) * | 2021-04-26 | 2021-07-16 | 河北医科大学第四医院 | 一种防治糖尿病足的干细胞组合物及其应用 |
| CN114404590A (zh) * | 2022-01-24 | 2022-04-29 | 四川大学华西医院 | TGF-β抑制剂在制备治疗糖尿病足的药物中的用途 |
Family Cites Families (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| KR20230146124A (ko) * | 2006-10-06 | 2023-10-18 | 셀룰래리티 인코포레이티드 | 천연(텔로펩티드) 태반 콜라겐 조성물 |
| LT2556145T (lt) * | 2010-04-07 | 2016-11-10 | Anthrogenesis Corporation | Angiogenezė naudojant placentos kamienines ląsteles |
| AR084754A1 (es) * | 2010-12-30 | 2013-06-05 | Anthrogenesis Corp | Composiciones que comprenden celulas madre de placenta y plasma rico en plaquetas, y sus metodos de uso |
-
2015
- 2015-09-25 EP EP15844825.8A patent/EP3197467A4/en not_active Withdrawn
- 2015-09-25 WO PCT/US2015/052276 patent/WO2016049485A1/en not_active Ceased
- 2015-09-25 JP JP2017516161A patent/JP2017537057A/ja active Pending
- 2015-09-25 US US15/509,710 patent/US20170290861A1/en not_active Abandoned
-
2020
- 2020-08-27 JP JP2020143608A patent/JP2021001178A/ja not_active Withdrawn
-
2022
- 2022-09-09 JP JP2022143365A patent/JP2022184911A/ja active Pending
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| Silini et al. | Perinatal derivatives: where do we stand? A roadmap of the human placenta and consensus for tissue and cell nomenclature | |
| JP2002517227A5 (ja) | 造血幹細胞を試験管内で維持する方法と組成物 | |
| AU2021203074A1 (en) | Placental-derived stem cells to restore the regenerative engine, correct proteomic defects and extend lifespan | |
| EA201100663A1 (ru) | Соединения, которые увеличивают количество гематопоэтических стволовых клеток | |
| MX2021004282A (es) | Construcciones de ácido nucleico y métodos de uso. | |
| CR20200392A (es) | Anticuerpos anti-cd73 y métodos de uso de los mismos | |
| PH12019500187A1 (en) | A method of isolating mesenchymal stem cells from umbilical cord amniotic membrane using a cell culture medium | |
| SA520411173B1 (ar) | Pd-l1 عوامل ربط ترتبط بـ واستخدامها cd137 | |
| JP2021001178A5 (https=) | ||
| BR112018076306A2 (pt) | composições e métodos para a supressão de células cd117+ | |
| CL2020002973A1 (es) | Casetes de expresión de a- glucosidasa de ácido optimizado con codón y métodos de uso del mismo | |
| WO2021127200A8 (en) | Ilt3-binding agents and methods of use thereof | |
| CY1116768T1 (el) | Συνθεσεις οι οποιες περιεχουν βλαστοκυτταρα θηλυκης γαμετικης σειρας και μεθοδοι χρησης αυτων | |
| MX2022005249A (es) | Anticuerpos anti-cd45 y conjugados de los mismos. | |
| MX2009009414A (es) | Obtencion, aislamiento y crioconservacion de celulas endometriales/menstruales. | |
| JP2021527039A5 (https=) | ||
| WO2021262597A3 (en) | Lair-1-binding agents and methods of use thereof | |
| NO20062709L (no) | Stamceller som er egnet for transplantasjon, fremstilling derav og farmasoytiske preperater omfattende nevnte stamceller | |
| CL2022003012A1 (es) | Anticuerpos anti-dectina-2 | |
| WO2006039396A3 (en) | Non-embedded tissue microarray technology for protein and nucleic acid analyses | |
| PL415351A1 (pl) | Sposób namnażania in vitro komórek T regulatorowych (Treg) | |
| JP2013177444A (ja) | ヒトｉＰＳのＴ細胞再分化テロメア若返り炎症老化止めｐ５３とＲｂ分解経口不老不死薬５ | |
| ECSP22004680A (es) | Anticuerpos anti-angpt2 | |
| CL2025003762A1 (es) | Formulaciones que comprenden proteína de unión al transcripto 7 similar a inmunoglobulina. | |
| AR120352A1 (es) | Anticuerpos anti-cd45 y sus conjugados |